Pharmaceutical firm AstraZeneca says it has not had any discussions with any U.S. government officials about an emergency use authorization for its coronavirus vaccine, Politico reports.
The company’s statement comes a day after the Financial Times reported the White House would consider how to grant an emergency use of the AstraZeneca vaccine if a late-stage clinical trial currently taking place in the U.K. and other countries has positive results.
